MetLife Investment Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.05M | Sell |
|
|||||
|
2025
Q1 | $3.46M | Sell |
|
|||||
|
2024
Q4 | $3.34M | Buy |
|
|||||
|
2024
Q3 | $2.15M | Hold |
|
|||||
|
2024
Q2 | $2.84M | Buy |
|
|||||
|
2024
Q1 | $2.03M | Sell |
|
|||||
|
2023
Q4 | $1.8M | Buy |
|
|||||
|
2023
Q3 | $1.05M | Hold |
|
|||||
|
2023
Q2 | $1.66M | Buy |
|
|||||
|
2023
Q1 | $1.62M | Hold |
|
|||||
|
2022
Q4 | $1.94M | Hold |
|
|||||
|
2022
Q3 | $434K | Hold |
|
|||||
|
2022
Q2 | $478K | Hold |
|
|||||
|
2022
Q1 | $656K | Buy |
|
|||||
|
2021
Q4 | $357K | Buy |
|
|||||
|
2021
Q3 | $294K | Hold |
|
|||||
|
2021
Q2 | $359K | Hold |
|
|||||
|
2021
Q1 | $431K | Hold |
|
|||||
|
2020
Q4 | $410K | Hold |
|
|||||
|
2020
Q3 | $438K | Hold |
|
|||||
|
2020
Q2 | $418K | Hold |
|
|||||
|
2020
Q1 | $246K | Hold |
|
|||||
|
2019
Q4 | $336K | Hold |
|
|||||
|
2019
Q3 | $318K | Hold |
|
|||||
|
2019
Q2 | $386K | Buy |
|
|||||
|
2019
Q1 | $391K | Hold |
|
|||||
|
2018
Q4 | $352K | Hold |
|
|||||
|
2018
Q3 | $669K | Buy |
|
|||||
|
2018
Q2 | $755K | Buy |
|
|||||
|
2018
Q1 | $247K | Hold |
|
|||||
|
2017
Q4 | $194K | Buy |
|